ArticleAJOG global reports2025
A low-middle income country experience: conventional hysterectomy vs conservative placenta accreta spectrum management.
Article in AJOG global reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Uterus-preserving surgery for placenta accreta spectrum: An expert, illustrated review of techniques and its outcomes.Acta obstetricia et gynecologica Scandinavica · 2026Review
- Strategies for streamlining uterine topographic classification in placenta accreta spectrum.AJOG global reports · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlacenta accreta spectrum is one of the most dangerous complications of pregnancy, and its incidence has been rising in recent years. The standard management approach is an elective cesarean-hysterectomy, but it presents with its own set of risks and complications. Although conservative management options exist, there is a lack of definitive guidelines and must be considered on a case-by-case basis.
objectiveThis study aimed to describe and compare the outcomes (surgical duration, intraoperative blood loss volume, and maternal mortality) of patients with placenta accreta spectrum who were treated with a hysterectomy and those treated with conservative surgery in the Dr. Cipto Mangunkusumo General Hospital, a tertiary referral hospital in Indonesia. STUDY
designData from 271 patients with placenta accreta spectrum at the Dr. Cipto Mangunkusumo General Hospital that were collected over 3.5 years were taken and analyzed in this retrospective cohort study. Data collected included the patients' age, reproductive history, placenta accreta index score, gestational age, emergency status, management method, type of hysterectomy, surgery duration, intraoperative blood loss volume, histopathologic data, and maternal mortality. The data were analyzed using the Statistical Package for Social Sciences, version 29, with statistical significance set at
resultsThere were no significant differences in the demographics and reproductive history between the hysterectomy and conservative surgery groups. There was considerable difference in terms of surgical duration, intraoperative blood loss, and placenta accreta index score. The hysterectomy group had longer surgeries (median 180 minutes vs 135 minutes;
conclusionIn this study, patients who underwent conservative surgical management for placenta accreta spectrum experienced shorter surgeries with less bleeding and no maternal death. These patients typically had lower placenta accreta index scores, which may have influenced the choice of management methods and affected surgical outcomes. Although conservative surgery is a viable option, patients and surgeons must carefully weigh the risks and benefits before deciding on a treatment approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.